- Home
- IBP vs AXSM Comparison
IBP vs AXSM Comparison
Compare IBP & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- AXSM
- Stock Information
- Founded
- IBP 1977
- AXSM 2012
- Country
- IBP United States
- AXSM United States
- Employees
- IBP N/A
- AXSM N/A
- Industry
- IBP Homebuilding
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- IBP Consumer Discretionary
- AXSM Health Care
- Exchange
- IBP Nasdaq
- AXSM Nasdaq
- Market Cap
- IBP 4.8B
- AXSM 5.3B
- IPO Year
- IBP 2014
- AXSM 2015
- Fundamental
- Price
- IBP $173.69
- AXSM $100.44
- Analyst Decision
- IBP Buy
- AXSM Strong Buy
- Analyst Count
- IBP 11
- AXSM 14
- Target Price
- IBP $226.00
- AXSM $168.93
- AVG Volume (30 Days)
- IBP 376.1K
- AXSM 642.7K
- Earning Date
- IBP 05-08-2025
- AXSM 05-05-2025
- Dividend Yield
- IBP 1.88%
- AXSM N/A
- EPS Growth
- IBP 5.69
- AXSM N/A
- EPS
- IBP 9.10
- AXSM N/A
- Revenue
- IBP $2,941,300,000.00
- AXSM $385,693,000.00
- Revenue This Year
- IBP $0.81
- AXSM $64.53
- Revenue Next Year
- IBP $5.09
- AXSM $63.26
- P/E Ratio
- IBP $18.20
- AXSM N/A
- Revenue Growth
- IBP 5.86
- AXSM 42.53
- 52 Week Low
- IBP $159.76
- AXSM $64.11
- 52 Week High
- IBP $281.04
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- IBP 39.44
- AXSM 32.26
- Support Level
- IBP $165.23
- AXSM $107.00
- Resistance Level
- IBP $176.98
- AXSM $122.97
- Average True Range (ATR)
- IBP 5.68
- AXSM 4.25
- MACD
- IBP -0.56
- AXSM -2.14
- Stochastic Oscillator
- IBP 21.84
- AXSM 3.84
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.